PREX1 and carcinoma: and while P-REX1 expression in breast cancer has been associated with worse prognosis of patients, genomic changes in P-REX1 or P-REX2 have been found in various human carcinomas other than melanoma such as in breast, prostate, colorectal, and lung cancer [7].